Oragenics (OGEN) Current Leases (2019 - 2023)
Oragenics' (OGEN) quarterly Current Leases came in at $9811.0 in Q4 2023, down 95.2% YoY from $204447.0 in Q4 2022, and down 59.69% on a QoQ basis from $24337.0 in Q3 2023.
Oragenics (OGEN) Current Leases (2019 - 2023) Analysis & Trends
Oragenics (OGEN) has 5 years of Current Leases data on file, last reported at $9811.0 in Q4 2023.
- Quarterly Current Leases fell 95.2% year-over-year to $9811.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $9811.0 (down 95.2% YoY) and the FY2023 annual result came in at $9811.0, down 95.2% from the prior year.
- Current Leases slipped to $9811.0 in Q4 2023, from $24337.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $204447.0 in Q4 2022 to a low of $9811.0 in Q4 2023.
- A 5-year average of $160987.2 and a median of $178862.0 in 2020 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases advanced 28.43% — and 2023, when it sank 95.2%.
- Tracing OGEN's Current Leases over 5 years: stood at $165096.0 in 2019, then gained by 7.15% to $176900.0 in 2020, then gained by 9.82% to $194270.0 in 2021, then advanced by 5.24% to $204447.0 in 2022, then slumped by 95.2% to $9811.0 in 2023.
- The last three Current Leases figures came in at $9811.0 (Q4 2023), $24337.0 (Q3 2023), and $190242.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 9,811.00 |
| Sep 30, 2023 | 24,337.00 |
| Jun 30, 2023 | 190,242.00 |
| Mar 31, 2023 | 202,187.00 |
| Dec 31, 2022 | 204,447.00 |
| Sep 30, 2022 | 201,973.00 |
| Jun 30, 2022 | 180,824.00 |
| Mar 31, 2022 | 192,535.00 |
| Dec 31, 2021 | 194,270.00 |
| Sep 30, 2021 | 190,181.00 |
| Jun 30, 2021 | 185,689.00 |
| Mar 31, 2021 | 181,260.00 |
| Dec 31, 2020 | 176,900.00 |
| Sep 30, 2020 | 173,536.00 |
| Jun 30, 2020 | 170,680.00 |
| Mar 31, 2020 | 167,864.00 |
| Dec 31, 2019 | 165,096.00 |
| Sep 30, 2019 | 135,120.00 |
| Jun 30, 2019 | 140,327.00 |
| Mar 31, 2019 | 132,465.00 |